These data are also consistent with previous observations by Collins et al. (2012) who demonstrated that higher SPP1 expression is beneficial since it was associated with an improved outcome in patients with pancreatic cancer [42]. This evidence concerns the gene SPP1 and familial pancreatic carcinoma.